scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education
BT Golf banking economy summit BT 500
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Indoco Remedies Ltd

Feedback
Indoco Remedies Ltd

Indoco Remedies Ltd (INDOCO) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 96,872
Jan 03, 2025 15:49 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹336.35
₹-1.25 (0.37%)
₹335.95 Low
Today’s Performance
₹343.65 High
₹286.6 Low
52 Week’s Performance
₹415 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -0.37%
  • 1 Week 1.36%
  • 1 Month 4.98%
  • 3 Months -0.94%
  • 6 Months -2.46%
  • 1 Year -13.92%
  • 3 Years -8.52%
  • 5 Years 12.69%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 0.73
  • 52-Week Low (₹) 286.60
  • 52-Week High (₹) 415.00
  • Price-to-Book (X)* 2.84
  • Dividend Yield (%) 0.45
  • Price-to-Earnings (P/E) (X)* 96.62
  • Earnings Per Share (₹) 3.48
  • Sector Price Earning (X)* 38.27
  • Market Cap (₹ Cr.)* 3,100.55
  • * Vaues as of last close price

COMPETITORS

BT TV

Mutual Funds 2025, Top Investments, Personal Finance, Mutual Fund Advice, Investment Tips, Business News 2:13 Beat The Market In 2025: Expert-Recommended Top Mutual Fund Schemes You Shouldn’t Miss!
Savers To Investors | Kotak Mahindra Bank CEO Ashok Vaswani On India’s New Investor Mindset 3:13 Savers To Investors | Kotak Mahindra Bank CEO Ashok Vaswani On India’s New Investor Mindset
Samir Arora On Why HDFC Bank Continues To Be A Key Stock In Portfolios 2:00 Samir Arora On Why HDFC Bank Continues To Be A Key Stock In Portfolios
Axis Bank’s Neelkanth Mishra Says The Indian Economy Is On The Mend Again 3:00 Axis Bank’s Neelkanth Mishra Says The Indian Economy Is On The Mend Again
IPO Market In 2025: Can Investors Expect Big Gains In The New Year? 2:25 IPO Market In 2025: Can Investors Expect Big Gains In The New Year?
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Oct 10, 2019 Sell
DSP AIF PHARMA FUND
  • Qty 1276434
  • Average Price ₹140.00
Oct 10, 2019 PURCHASE
DSP MUTUAL FUND
  • Qty 1276434
  • Average Price ₹140.00
Oct 27, 2015 PURCHASE
BARCLAYS MERCHANT BANK (SINGAPORE) LTD
  • Qty 2149206
  • Average Price ₹336.00
Oct 27, 2015 Sell
BARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD
  • Qty 2149206
  • Average Price ₹336.00
Oct 20, 2015 PURCHASE
BARCLAYS MERCHANT BANK (SINGAPORE) LTD
  • Qty 632020
  • Average Price ₹326.75
Oct 20, 2015 Sell
BARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD
  • Qty 632020
  • Average Price ₹326.75
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Aug 12, 2021 PURCHASE
XTX MARKETS LLP
  • Qty 478901
  • Average Price ₹507.94
Aug 12, 2021 Sell
XTX MARKETS LLP
  • Qty 481713
  • Average Price ₹508.51
Dec 02, 2020 Sell
OHM JUNIPER LONGTERM FUND LTD
  • Qty 500000
  • Average Price ₹265.31
Dec 02, 2020 PURCHASE
DOVETAIL INDIA FUND CLASS 6 SHARES
  • Qty 500000
  • Average Price ₹265.31
Oct 10, 2019 PURCHASE
DSP MUTUAL FUND
  • Qty 1276434
  • Average Price ₹140.00
Oct 10, 2019 Sell
DSP AIF PHARMA FUND
  • Qty 1276434
  • Average Price ₹140.00
Jun 07, 2018 Sell
DSP BLACKROCK MUTUAL FUND
  • Qty 1000000
  • Average Price ₹190.01
Jun 07, 2018 Sell
DSP BLCKROCK MUTUAL FUND
  • Qty 500000
  • Average Price ₹190.00
Jun 07, 2018 Sell
DSP BLCKROCK MUTUAL FUND
  • Qty 500000
  • Average Price ₹190.00
Jan 24, 2018 Sell
INDIA WHIZDOM FUND
  • Qty 588800
  • Average Price ₹280.00
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Indoco Remedies Ltd share price previously?
Indoco Remedies Ltd share price was down by -0.37% from the previous closing price of ₹337.60.
Who are peers of Indoco Remedies Ltd?
The peers of Indoco Remedies Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Mankind Pharma Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Indoco Remedies Ltd?
The promotor/promotors of Indoco Remedies Ltd are Suresh G Kare, Aditi Kare Panandikar, Sundeep V Bambolkar, Vasudha V Kamat, Abhijit Y Gore, Anand Nadkarni, Ajay Mulgaokar, Satish Shenoy, Ramanathan Hariharan.
What has been 52-week high of Indoco Remedies Ltd stocks?
The highest price of Indoco Remedies Ltd stock is ₹415.00 in the last 52-week.
What is the share price of Indoco Remedies Ltd (INDOCO) today on NSE?
As on Jan 03, 2025, Indoco Remedies Ltd (INDOCO)’s share price on NSE is Rs 336.35
What is the market cap of Indoco Remedies Ltd (INDOCO?)
The current market capitalisation of Indoco Remedies Ltd (INDOCO) is 3,100.55 crores
What is Indoco Remedies Ltd Share symbol?
The symbol of Indoco Remedies Ltd is INDOCO.
What is the PE ratio of Indoco Remedies Ltd (INDOCO)?
The current PE ratio of Indoco Remedies Ltd (INDOCO) is 96.62.
What is the PB ratio of Indoco Remedies Ltd (INDOCO)?
The current PB ratio of Indoco Remedies Ltd (INDOCO) is 2.84.
Today’s High & Low share prices of Indoco Remedies Ltd (INDOCO) on NSE?
Today, the share price of Indoco Remedies Ltd (INDOCO) on NSE touched a high of Rs 343.65 and a low of Rs 335.95
What price did Indoco Remedies Ltd (INDOCO) shares open on the NSE today?
On NSE, the share price of Indoco Remedies Ltd (INDOCO) opened at Rs 336
What is the 52-week high of Indoco Remedies Ltd (INDOCO)?
The 52-week high price of Indoco Remedies Ltd (INDOCO) is Rs 415
What is the 52-week low of Indoco Remedies Ltd (INDOCO) ?
The 52-week low price of Indoco Remedies Ltd (INDOCO) is Rs 286.6

ABOUT INDOCO REMEDIES

Indoco Remedies Ltd, incorporated in the year 1947, has its registered office in Indoco House 166 C S T Road, Santacruz (East) Kalina, Mumbai, Maharashtra, 400098, 91-022-26541851-55, 91-022-26520787. The main industry in which Indoco Remedies Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Indoco Remedies Ltd is/are Gokhale & Sathe. In the main management, Suresh G Kare is chairman and Ramanathan Hariharan is the company secretary for Indoco Remedies Ltd.

  • SGK Suresh G Kare Chairman (Non-Executive)
  • AKP Aditi Kare Panandikar Managing Director
  • SVB Sundeep V Bambolkar Joint Managing Director
  • VVK Vasudha V Kamat Independent Non Exe. Director
  • AYG Abhijit Y Gore Independent Non Exe. Director
  • AN Anand Nadkarni Non Executive Director
  • AM Ajay Mulgaokar Independent Non Exe. Director
  • SS Satish Shenoy Independent Non Exe. Director
  • RH Ramanathan Hariharan Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement